Befejeződött1. fázis
A Phase 1b, Open-Label, Multiple Ascending Dose, Multicenter Study of VRG50635 in Participants With Sporadic and Familial Amyotrophic Lateral Sclerosis Followed by Long-Term Treatment
Key facts
- Where
- Helsinki, Kuopio, Tampere és Turku, FinnországSee the 4 sites
- Phase
- 1. fázis
Where in Finnország
- Meilahti HospitalHelsinki, FinnországNo longer taking part
- University Of Eastern FinlandKuopio, FinnországNo longer taking part
- Tampere University HospitalTampere, FinnországNo longer taking part
- Turku University HospitalTurku, FinnországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Verge Genomics
- Trial code
- EU 2023-506509-21-00
- Record updated
- 2025. július 14.